Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?
- PMID: 29737013
- PMCID: PMC6035086
- DOI: 10.1111/sdi.12701
Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?
Abstract
While many patients have substantial residual kidney function (RKF) when initiating hemodialysis (HD), most patients with end stage renal disease in the United States are initiated on 3-times per week conventional HD regimen, with little regard to RKF or patient preference. RKF is associated with many benefits including survival, volume control, solute clearance, and reduced inflammation. Several strategies have been recommended to preserve RKF after HD initiation, including an incremental approach to HD initiation. Incremental HD prescriptions are personalized to achieve adequate volume control and solute clearance with consideration to a patient's endogenous renal function. This allows the initial use of less frequent and/or shorter HD treatment sessions. Regular measurement of RKF is important because HD frequency needs to be increased as RKF inevitably declines. We narratively review the results of 12 observational cohort studies of twice-weekly compared to thrice-weekly HD. Incremental HD is associated with several benefits including preservation of RKF as well as extending the event-free life of arteriovenous fistulas and grafts. Patient survival and quality of life, however, has been variably associated with incremental HD. Serious risks must also be considered, including increased hospitalization and mortality perhaps related to fluid and electrolyte shifts after a long interdialytic interval. On the basis of the above literature review, and our clinical experience, we suggest patient characteristics which may predict favorable outcomes with an incremental approach to HD. These include substantial RKF, adequate volume control, lack of significant anemia/electrolyte imbalance, satisfactory health-related quality of life, low comorbid disease burden, and good nutritional status without evidence of hypercatabolism. Clinicians should engage patients in on-going conversations to prepare for incremental HD initiation and to ensure a smooth transition to thrice-weekly HD when needed.
© 2018 Wiley Periodicals, Inc.
Conflict of interest statement
KK-Z has received honoraria and/or support from Abbott, Abbvie, Alexion, Amgen, the American Society of Nephrology, Astra-Zeneca, Aveo, Chugai, DaVita, Fresenius, Genetech, Haymarket Media, Hospira, Kabi, Keryx, the National Institutes of Health, the National Kidney Foundation, Relypsa, Resverlogix, Sanofi, Shire, Vifor, and ZS-Pharma.
The other authors declare no conflicts of interest.
Figures
Similar articles
-
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.Am J Kidney Dis. 2016 Aug;68(2):256-265. doi: 10.1053/j.ajkd.2016.01.008. Epub 2016 Feb 9. Am J Kidney Dis. 2016. PMID: 26867814 Free PMC article.
-
Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.Am J Kidney Dis. 2014 Aug;64(2):181-6. doi: 10.1053/j.ajkd.2014.04.019. Epub 2014 May 17. Am J Kidney Dis. 2014. PMID: 24840669 Free PMC article. Review.
-
Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.Am J Nephrol. 2019;50(6):411-421. doi: 10.1159/000503805. Epub 2019 Oct 18. Am J Nephrol. 2019. PMID: 31630148 Review.
-
Ultrafiltration Rate, Residual Kidney Function, and Survival Among Patients Treated With Reduced-Frequency Hemodialysis.Am J Kidney Dis. 2020 Mar;75(3):342-350. doi: 10.1053/j.ajkd.2019.08.019. Epub 2019 Dec 6. Am J Kidney Dis. 2020. PMID: 31813665 Free PMC article.
-
What Is Known and Unknown About Twice-Weekly Hemodialysis.Blood Purif. 2015;40(4):298-305. doi: 10.1159/000441577. Epub 2015 Nov 17. Blood Purif. 2015. PMID: 26656764 Free PMC article.
Cited by
-
A mixed-method feasibility study of a novel transitional regime of incremental haemodialysis: study design and protocol.Clin Exp Nephrol. 2021 Oct;25(10):1131-1141. doi: 10.1007/s10157-021-02072-1. Epub 2021 Jun 8. Clin Exp Nephrol. 2021. PMID: 34101030 Free PMC article.
-
Incremental and Personalized Hemodialysis Start: A New Standard of Care.Kidney Int Rep. 2022 Feb 19;7(5):1049-1061. doi: 10.1016/j.ekir.2022.02.010. eCollection 2022 May. Kidney Int Rep. 2022. PMID: 35571001 Free PMC article.
-
Choice of the Dialysis Modality: Practical Considerations.J Clin Med. 2023 May 7;12(9):3328. doi: 10.3390/jcm12093328. J Clin Med. 2023. PMID: 37176768 Free PMC article. Review.
-
Incremental hemodialysis in pediatric patients.J Nephrol. 2023 Jul;36(6):1571-1580. doi: 10.1007/s40620-023-01668-y. Epub 2023 Jun 21. J Nephrol. 2023. PMID: 37341967
-
Twice against thrice-weekly hemodialysis (TATH): a multicenter nonrandomized trial.BMC Nephrol. 2025 Apr 5;26(1):176. doi: 10.1186/s12882-025-04105-3. BMC Nephrol. 2025. PMID: 40188011 Free PMC article. Clinical Trial.
References
-
- United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2017.
-
- Shafi T, Mullangi S, Toth-Manikowski SM, Hwang S, Michels WM. Residual Kidney Function: Implications in the Era of Personalized Medicine. Semin Dial. 2017;30:241–5. - PubMed
-
- Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS) Kidney International. 1985;28:526–34. - PubMed
-
- Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical